Literature DB >> 35780621

Evaluating the neuroprotective activities of vinpocetine, punicalagin, niacin and vitamin E against behavioural and motor disabilities of manganese-induced Parkinson's disease in Sprague Dawley rats.

Karema Abu-Elfotuh1, Ahmed Mohsen Elsaid Hamdan2, Ashwaq Najemaldeen Abbas3, Abdulelah Turki S Alahmre4, Mohammed A F Elewa5, Rehab Ali Elsayed Masoud6, Azza A Ali1, Mohamed Othman7, Mona M Kamal1, Fatma Alzahraa M Hassan8, Mona G Khalil9, Ahmed M El-Sisi10, Manal M M Abdel Hady11, Marwa Khaled Abd-Elhaleim El Azazy12, Magdy M Awny13, Ahmed Wahid14.   

Abstract

The current study investigated the neuroprotective activity of some drugs and nutriceuticals with antioxidant and anti-inflammatory potential on the pathogenesis of Parkinson's disease (PD). Rats were categorized into seven groups: Rats received tween80 daily for 5 weeks as a control group, MnCl2 (10 mg/kg, i.p) either alone (group II) or in combination with vinpocetine (VIN) (20 mg/kg) (group III), punicalagin (PUN) (30 mg/kg) (group IV), niacin (85 mg/kg) (group V), vitamin E (Vit E) (100 mg/kg) (group VI) or their combination (group VII). Motor activities was examined using open-field and catalepsy. Striatal monamines, acetylcholinesterase, excitatory/inhibitory neurotransmitters, redox status, pro-oxidant content, brain inflammatory, apoptotic and antioxidant biomarkers levels were assessed. Besides, histopathological investigations of different brain regions were determined. Groups (IV -GVII) showed improved motor functions of PD rats. Applied drugs significantly increased the brain levels of monoamines with the strongest effect to PUN. Meanwhile, they significantly decreased levels of acetylcholinesterase with a strongest effect to PUN. Moreover, they exhibited significant neuronal protection and anti-inflammatory abilities through significant reduction of the brain levels of COX2, TNF-α and Il-1β with a strongest effect to the PUN. Interestingly; groups (IV - GVII) showed restored glutamate/GABA balance and exhibited a pronounced decrease in caspase-3 content and GSK-3β protein expression levels. In addition, they significantly increased Bcl2 mRNA expression levels with a strongest effect for PUN. All these findings were further confirmed by the histopathological examinations. As a conclusion, we propose VIN and PUN to mitigate the progression of PD via their antioxidant, anti-inflammatory, anti-apoptotic, neurotrophic and neurogenic activities.
Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Niacin; Oxidative stress; Parkinson’s disease; Punicalagin; Vinpocetine; Vitamin E

Mesh:

Substances:

Year:  2022        PMID: 35780621     DOI: 10.1016/j.biopha.2022.113330

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   7.419


  1 in total

1.  Vinpocetine restores cognitive and motor functions in Traumatic brain injury challenged rats.

Authors:  Kajal Bagri; Rahul Deshmukh
Journal:  Inflammopharmacology       Date:  2022-10-03       Impact factor: 5.093

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.